Waltham-based EarlySense Inc. said today it has received U.S. Food and Drug Administration clearance for an updated version of its bedside system that monitors and documents vital signs in patients.
"EarlySense is the first in the world to combine contact-free respiratory, cardiac and motion monitoring with oximetry. This means, that for the first time ever, hospitals have the ability to monitor the oxygen saturation of a patient in addition to automatically, continuously and in a contact-free manner, monitor that same patient's vital signs and movement," said EarlySense CEO Avner Halperin. "The oximetry component, meant for post-surgical patients who require a higher level of supervision, seamlessly integrates into the existing EarlySense system, including the central display station. The combination of deliverables provides clinicians with a flexible tool to facilitate individualized care plans for optimal clinical outcomes on the medical surgical floors."
The new oximetry feature of the EarlySense System will be introduced at Medica 2012 in Germany next month and officially launched into the market in 2013. The EarlySense System is a contact-free, patient monitoring solution that measures vital signs and movement using a sensor that slips under a bed mattress.
Anda sedang membaca artikel tentang
EarlySense wins FDA clearance for new bedside-monitoring system
Dengan url
http://wartegjokowi.blogspot.com/2012/10/earlysense-wins-fda-clearance-for-new.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
EarlySense wins FDA clearance for new bedside-monitoring system
namun jangan lupa untuk meletakkan link
EarlySense wins FDA clearance for new bedside-monitoring system
sebagai sumbernya
0 komentar:
Posting Komentar